Stablepharma is delighted to welcome Dr Kenny Simmen to the Advisory Board, who brings over 30 years pharmaceutical expertise in R&D with a successful track record in drug discovery and external innovation. Dr Simmen will work closely with the science and commercial teams to support further R&D deals and evaluate suitable vaccine candidates that will […]
Read More
click here to read full article
Read More
The United Kingdom is a hub for innovative startups and companies in the realm of impact investing, a variety of investing that seeks to generate both financial return and social or environmental good. Impact investing is fast gaining traction as we move towards a more responsible and sustainable way of doing business. It aligns money […]
Read More
Researchers at University Hospital Southampton (UHS) are working with Stablepharma Ltd to trial vaccines that don’t need to be kept cold. The partners have been awarded a joint grant by Innovate UK to develop a fridge-free vaccine, SPVX02, to prevent tetanus and diphtheria.
Read More
Stablepharma Ltd, the Fridge-free Vaccine Company, has been awarded a second Innovate UK Grant, in partnership with University Hospital Southampton NHS Foundation Trust, as it commences a bridge-funding round in Q4 2023. This joint Innovate UK grant will advance the clinical development of Stablepharma’s lead candidate, SPVX02, a fridge-free vaccine for the prevention of Tetanus […]
Read More
Dr Ceri Morgan and Richard Lane join the Stablepharma Ltd Advisory Board at a time of growth and investment. Stablepharma Ltd is delighted to announce two new members who will join the Advisory Board with immediate effect – Richard Lane, an experienced corporate lawyer and Dr Ceri Morgan, Senior Advisor & NED, specialising in capital […]
Read More
Stablepharma Ltd, the Fridge-free Vaccine Company and BB-NCIPD Ltd (Bul Bio) European vaccine manufacturer, have signed a second agreement for the exclusive bulk supply and commercialisation of the Tetanus vaccine (SPVX06). This agreement follows a similar arrangement with Bul Bio for the Tetanus diphtheria vaccine (SPVX02) in September 2022. “As a result of this strategic […]
Read More
Stablepharma Ltd is delighted to announce that Lorena Carmona-Rodiguez is joining the Science Team at our R&D Centre in Madrid, Spain. Lorena joins ‘The Fridge-free Vaccine Company’ as Senior Scientist to specifically progress our mRNA-LNP programme. Lorena has a Master’s Degree and PhD in Molecular Biosciences from the Universidad Autónoma de Madrid. She was, until […]
Read More
It is with great sadness and regret that the Board of Stablepharma has to announce the unexpected passing of Martin Powell on the 1st of May 2023. As our colleague and fellow Director, Martin was someone who made substantial contributions to the company since the early days and we will all miss his company, enthusiasm […]
Read More